Mimicking the structure of the V3 epitope bound to HIV-1 neutralizing antibodies

Biochemistry

Volumn 48, Issue 15, 2009, Pages 3288-3303

  Mor, Amit ^a   Segal, Eugenia ^a   Mester, Brenda ^a   Arshava, Boris ^b   Rosen, Osnat ^a   Ding, Fa Xiang ^b   Russo, Joseph ^b   Dafni, Amnon ^a   Schvartzman, Fabian ^a   Scherf, Tali ^a   Naider, Fred ^b   Anglister, Jacob ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AQUEOUS SOLUTIONS; CHEMOKINE; CONFORMATIONAL SPACES; CYCLIC PEPTIDES; DISULFIDE BONDS; ENVELOPE GLYCOPROTEINS; FREE FORMS; HAIRPIN CONFORMATIONS; NEUTRALIZING ANTIBODIES; NMR STRUCTURES; NMR STUDIES; RING SIZES;

ANTIBODIES; MANGANESE COMPOUNDS; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PEPTIDES; VIRUSES;

AMINES;

DISULFIDE; EPITOPE; HUMAN IMMUNODEFICIENCY VIRUS 1 NEUTRALIZING ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS PROTEIN; NEUTRALIZING ANTIBODY; PEPTIDE; UNCLASSIFIED DRUG;

ANTIGEN BINDING; ANTIGEN STRUCTURE; AQUEOUS SOLUTION; ARTICLE; CHEMICAL BOND; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN PROTEIN INTERACTION; RIGIDITY; STRUCTURE ANALYSIS;

AMINO ACID SEQUENCE; ANTIBODIES, VIRAL; BINDING SITES, ANTIBODY; DISULFIDES; EPITOPES; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR MIMICRY; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; PEPTIDES; PROTEIN BINDING; PROTEIN CONFORMATION; RECEPTORS, CCR5; RECEPTORS, CXCR4;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 65249116957     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi802308n     Document Type: Article

References (76)

1. Rusche, J. R., Javaherian, K., McDanal, C., Petro, J., Lynn, D. L., Grimaila, R., Langlois, A., Gallo, R. C., Arthur, L. O., Fischinger, P. J., et al. (1988) Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120. Proc. Natl. Acad. Sci. U. S. A. 85, 3198-3202.
2. Wu, L., Gerard, N. P., Wyatt, R., Choe, H., Parolin, C., Ruffing, N., Borsetti, A., Cardoso, A. A., Desjardin, E., Newman, W., Gerard, C., and Sodroski, J. (1996) CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature (London) 384, 179-183.
3. Trkola, A., Dragic, T., Arthos, J., Binley, J. M., Olson, W. C., Allaway, G. P., Cheng-Mayer, C., Robinson, J., Maddon, P. J., and Moore, J. P. (1996) CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature (London) 384, 184-187.
4. Liao, H. X., Etemad-Moghadam, B., Montefiori, D. C., Sun, Y., Sodroski, J., Scearce, R. M., Doms, R. W., Thomasch, J. R., Robinson, S., Letvin, N. L., and Haynes, B. F. (2000) Induction of antibodies in guinea pigs and rhesus monkeys against the human immunodeficiency virus type 1 envelope: neutralization of nonpathogenic and pathogenic primary isolate simian/human immunodeficiency virus strains. J. Virol. 74, 254-263.
5. Letvin, N. L., Robinson, S., Rohne, D., Axthelm, M. K., Fanton, J. W., Bilska, M., Palker, T. J., Liao, H. X., Haynes, B. F., and Montefiori, D. C. (2001) Vaccine-elicited V3 loop-specific antibodies in rhesus monkeys and control of a simian-human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate envelope. J. Virol. 75, 4165-4175.
6. Someya, K., Cecilia, D., Ami, Y., Nakasone, T., Matsuo, K., Burda, S., Yamamoto, H, Yoshino, N., Kaizu, M., Ando, S., Okuda, K., Zolla-Pazner, S., Yamazaki, S., Yamamoto, N., and Honda, M. (2005) Vaccination of rhesus macaques with recombinant Myco-bacterium bovis bacillus Calmette-Guerin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif. J. Virol. 79, 1452-1462.
7. Hewer, R., and Meyer, D. (2005) Evaluation of a synthetic vaccine construct as antigen for the detection of HIV-induced humoral responses. Vaccine 23, 2164-2167.
8. Golding, B., Eller, N., Levy, L., Beining, P., Inman, J., Matthews, N., Scott, D. E., and Golding, H. (2002) Mucosal immunity in mice immunized with HIV-1 peptide conjugated to Brucella abortus. Vaccine 20, 1445-1450.
9. Haynes, B. F., Ma, B., Montefiori, D. C., Wrin, T., Petropoulos, C. J., Sutherland, L. L., Scearce, R. M., Denton, C., Xia, S. M., Korber, B. T., and Liao, H. X. (2006) Analysis of HIV-1 subtype B third variable region peptide motifs for induction of neutralizing antibodies against HIV-1 primary isolates. Virology 345, 44-55.
10. Zvi, A., Hiller, R., and Anglister, J. (1992) Solution conformation of a peptide corresponding to the principal neutralizing determinant of HIV-1IIIB: a two-dimensional NMR study. Biochemistry 31, 6972-6979.
11. Chandrasekhar, K., Profy, A. T., and Dyson, H. J. (1991) Solution conformational preferences of immunogenic peptides derived from the principal neutralizing determinant of the HIV-1 envelope glycoprotein gp120. Biochemistry 30, 9187-9194.
12. Sharon, M., Rosen, O., and Anglister, J. (2005) NMR studies of V3 peptide complexes with antibodies suggest a mechanism for HIV-1 co-receptor selectivity. Curr. Opin. Drug Discovery Dev. 8, 601-612.
13. Matsushita, S., Robert Guroff, M., Rusche, J., Koito, A., Hattori, T., Hoshino, H., Javaherian, K., Takatsuki, K., and Putney, S. (1988) Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope. J. Virol. 62, 2107-2114.
14. Gorny, M. K., Xu, J. Y., Karwowska, S., Buchbinder, A., and Zolla-Pazner, S. (1993) Repertoire of neutralizing human monoclonal antibodies specific for the V3 domain of HIV-1 gp120. J. Immunol. 150, 635-643.
15. Gorny, M. K., Revesz, K., Williams, C., Volsky, B., Louder, M. K., Anyangwe, C. A., Krachmarov, C., Kayman, S. C., Pinter, A., Nadas, A., Nyambi, P. N., Mascola, J. R., and Zolla-Pazner, S. (2004) The v3 loop is accessible on the surface of most human immunodeficiency virus type 1 primary isolates and serves as a neutralization epitope. J. Virol. 78, 2394-2404.
16. Binley, J. M., Wrin, T., Korber, B., Zwick, M. B., Wang, M., Chappey, C., Stiegler, G., Kunert, R., Zolla-Pazner, S., Katinger, H, Petropoulos, C. J., and Burton, D. R. (2004) Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies. J. Virol. 78, 13232-13252.
17. Sharon, M., Kessler, N., Levy, R., Zolla-Pazner, S., Gorlach, M., and Anglister, J. (2003) Alternative Conformations of HIV-1 V3 Loops mimic beta hairpins in chemokines, suggesting a mechanism for coreceptor selectivity. Structure 11, 225-236.
18. IIIB V3 peptide. Nat. Struct. Biol. 6, 331-315.
19. Tugarinov, V., Zvi, A., Levy, R., Hayek, Y., Matsushita, S., and Anglister, J. (2000) NMR structure of an anti-gp120 antibody complex with a V3 peptide reveals a surface important for coreceptor binding. Struct. Fold Des. 8, 385-395.
20. Rosen, O., Chill, J., Sharon, M., Kessler, N., Mester, B., Zolla-Pazner, S., and Anglister, J. (2005) Induced fit in HIV-neutralizing antibody complexes: evidence for alternative conformations of the gp120 V3 loop and the molecular basis for broad neutralization. Biochemistry 44, 7250-7258.
21. Rosen, O., Sharon, M., Quadt-Akabayov, S. R., and Anglister, J. (2006) Molecular switch for alternative conformations of the HIV-1 V3 region: implications for phenotype conversion. Proc. Natl. Acad. Sci. U. S. A. 103, 13950-13955.
22. Ghiara, J. B., Stura, E. A., Stanfield, R. L., Profy, A. T., and Wilson, I. A. (1994) Crystal structure of the principal neutralization site of HIV-1. Science 264, 82-85.
23. Rini, J. M., Stanfield, R. L., Stura, E. A., Salinas, P. A., Profy, A. T., and Wilson, I. A. (1993) Crystal structure of a human immunodeficiency virus type 1 neutralizing antibody, 50.1, in complex with its V3 loop peptide antigen. Proc. Natl. Acad. Sci. U. S. A. 90, 6325-6329.
24. Stanfield, R., Cabezas, E., Satterthwait, A., Stura, E., Profy, A., and Wilson, I. (1999) Dual conformations for the HIV-1 gp120 V3 loop in complexes with different neutralizing Fabs. Structure 7, 131-142.
25. Stanfield, R. L., Ghiara, J. B., Ollmann Saphire, E., Profy, A. T., and Wilson, I. A. (2003) Recurring conformation of the human immunodeficiency virus type 1 gp120 V3 loop. Virology 315, 159-173.
26. Stanfield, R. L., Gorny, M. K., Zolla-Pazner, S., and Wilson, I. A. (2006) Crystal structures of human immunodeficiency virus type 1 (HIV-1) neutralizing antibody 2219 in complex with three different V3 peptides reveal a new binding mode for HIV-1 cross-reactivity. J. Virol. 80, 6093-6105.
27. Bell, C. H., Pantophlet, R., Schiefner, A., Cavacini, L. A., Stanfield, R. L., Burton, D. R., and Wilson, I. A. (2008) Structure of antibody F425-B4e8 in complex with a V3 peptide reveals a new binding mode for HIV-1 neutralization. J. Mol. Biol. 375, 969-978.
28. Stanfield, R. L., Gorny, M. K., Williams, C., Zolla-Pazner, S., and Wilson, I. A. (2004) Structural rationale for the broad neutralization of HIV-1 by human monoclonal antibody 447-52D. Structure (Camb) 12, 193-204.
29. Huang, C. C., Tang, M., Zhang, M. Y., Majeed, S., Montabana, E., Stanfield, R. L., Dimitrov, D. S., Korber, B., Sodroski, J., Wilson, I. A., Wyatt, R., and Kwong, P. D. (2005) Structure of a V3-containing HIV-1 gp120 core. Science 310, 1025-1028.
30. Huang, C. C., Lam, S. N., Acharya, P., Tang, M., Xiang, S. H., Hussan, S. S., Stanfield, R. L., Robinson, J., Sodroski, J., Wilson, I. A., Wyatt, R., Bewley, C. A., and Kwong, P. D. (2007) Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4. Science 317 1930-1934.
31. Santiveri, C. M., Leon, E., Rico, M., and Jimenez, M. A. (2008) Context-dependence of the contribution of disulfide bonds to betahairpin stability. Chemistry 14, 488-499.
32. Hutchinson, E. G., Sessions, R. B., Thornton, J. M., and Woolfson, D. N. (1998) Determinants of strand register in antiparallel betasheets of proteins. Protein Sci. 7, 2287-2300.
33. Chakraborty, K., Durani, V., Miranda, E. R., Citron, M., Liang, X., Schleif, W., Joyce, J. G., and Varadarajan, R. (2006) Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies. Biochem. J. 399, 483-491.
34. Conley, A. J., Conard, P., Bondy, S., Dolan, C. A., Hannah, J., Leanza, W. J., Marburg, S., Rivetna, M., Rusiecki, V. K., Sugg, E. E., et al. (1994) Immunogenicity of synthetic HIV-1 gp120 V3-loop peptide-conjugate immunogens. Vaccine 12, 445-451.
35. Cabezas, E., Wang, M., Parren, P. W., Stanfield, R. L., and Satterthwait, A. C. (2000) A structure-based approach to a synthetic vaccine for HIV-1. Biochemistry 39, 14377-14391.
36. FitzGerald, D. J., Fryling, C. M., McKee, M. L., Vennari, J. C., Wrin, T., Cromwell, M. E., Daugherty, A. L., and Mrsny, R. J. (1998) Characterization of V3 loop-Pseudomonas exotoxin chimeras. Candidate vaccines for human immunodeficiency virus-1. J. Biol. Chem. 273, 9951-9958.
37. Bryder, K., Sbai, H., Nielsen, H. V., Corbet, S., Nielsen, C., Whalen, R. G., and Fomsgaard, A. (1999) Improved immunogenicity of HIV-1 epitopes in HBsAg chimeric DNA vaccine plasmids by structural mutations of HBsAg. DNA Cell Biol. 18, 219-225.
38. Backstrom, M., Lebens, M., Schodel, F., and Holmgren, J. (1994) Insertion of a HIV-1-neutralizing epitope in a surface-exposed internal region of the cholera toxin B-subunit. Gene 149, 211-217.
39. Fontenot, J. D., Gatewood, J. M., Mariappan, S. V., Pau, C. P., Parekh, B. S., George, J. R., and Gupta, G. (1995) Human immunodeficiency virus (HIV) antigens: structure and serology of multivalent human mucin MUC1-HIV V3 chimeric proteins. Proc. Natl. Acad. Sci. U. S. A. 92, 315-319.
40. Scodeller, E. A., Tisminetzky, S. G., Porro, F., Schiappacassi, M., De Rossi, A., Chiecco-Bianchi, L., and Baralle, F. E. (1995) A new epitope presenting system displays a HIV-1 V3 loop sequence and induces neutralizing antibodies. Vaccine 13, 1233-1239.
41. Resnick, D. A., Smith, A. D., Gesiler, S. C., Zhang, A., Arnold, E., and Arnold, G. F. (1995) Chimeras from a human rhinovirus 14-human immunodeficiency virus type 1 (HIV-1) V3 loop seroprevalence library induce neutralizing responses against HIV-1. J. Virol. 69, 2406-2411.
42. Perham, R. N., Terry, T. D., Willis, A. E., Greenwood, J., di Marzo Veronese, F., and Appella, E. (1995) Engineering a peptide epitope display system on filamentous bacteriophage. FEMS Microbiol. Rev. 17, 25-31.
43. Oggioni, M. R., Medaglini, D., Romano, L., Peruzzi, F., Maggi, T., Lozzi, L., Bracci, L., Zazzi, M., Manca, F., Valensin, P. E., and Pozzi, G. (1999) Antigenicity and immunogenicity of the V3 domain of HIV type 1 glycoprotein 120 expressed on the surface of Streptococcus gordonii. AIDS Res. Hum. Retroviruses 15, 451- 459.
44. Zolla-Pazner, S., Cohen, S. S., Krachmarov, C., Wang, S., Pinter, A., and Lu, S. (2008) Focusing the immune response on the V3 loop, a neutralizing epitope of the HIV-1 gp120 envelope. Virology 372, 233-246.
45. Vranken, W. F., Budesinsky, M., Fant, F., Boulez, K., and Borremans, F. A. (1995) The complete consensus V3 loop peptide of the envelope protein gp120 of HIV-1 shows pronounced helical character in solution. FEBS Lett. 374, 117-121.
46. Markert, R. L., Ruppach, H., Gehring, S., Dietrich, U., Mierke, D. F., Kock, M., Rubsamen-Waigmann, H., and Griesinger, C. (1996) Secondary structural elements as a basis for antibody recognition in the immunodominant region of human immunodeficiency viruses 1 and 2. Eur. J. Biochem. 237, 188-204.
47. Ofek, G., Tang, M., Sambor, A., Katinger, H., Mascola, J. R., Wyatt, R., and Kwong, P. D. (2004) Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope. J. Virol. 78, 10724-10737.
48. Cardoso, R. M., Zwick, M. B., Stanfield, R. L., Kunert, R., Binley, J. M., Katinger, H., Burton, D. R., and Wilson, I. A. (2005) Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41. Immunity 22, 163-173.
49. Saphire, E. O., Parren, P. W., Pantophlet, R., Zwick, M. B., Morris, G. M., Rudd, P. M., Dwek, R. A., Stanfield, R. L., Burton, D. R., and Wilson, I. A. (2001) Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design. Science 293, 1155-1159.
50. Calarese, D. A., Lee, H. K., Huang, C. Y., Best, M. D., Astronomo, R. D., Stanfield, R. L., Katinger, H., Burton, D. R., Wong, C. H., and Wilson, I. A. (2005) Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12. Proc. Natl. Acad. Sci. U. S. A. 102, 13372-13377.
51. Wu, X., Sambor, A., Nason, M. C., Yang, Z. Y., Wu, L., Zolla-Pazner, S., Nabel, G. J., and Mascola, J. R. (2008) Soluble CD4 broadens neutralization of V3-directed monoclonal antibodies and guinea pig vaccine sera against HIV-1 subtype B and C reference viruses. Virology 380, 285-295.
52. Van Herrewege, Y., Morellato, L., Descours, A., Aerts, L., Michiels, J., Heyndrickx, L., Martin, L., and Vanham, G. (2008) CD4 mimetic miniproteins: potent anti-HIV compounds with promising activity as microbicides. J. Antimicrob. Chemother. 61, 818-826.
53. Madani, N., Schon, A., Princiotto, A. M., Lalonde, J. M., Courter, J. R., Soeta, T., Ng, D., Wang, L., Brower, E. T., Xiang, S. H., Do Kwon, Y., Huang, C. C., Wyatt, R., Kwong, P. D., Freire, E., Smith, A. B., 3rd., and Sodroski, J. (2008) Small-molecule CD4 mimics interact with a highly conserved pocket on HIV-1 gp120. Structure 16, 1689-1701.
54. Kamber, B., Hartmann, A., Eisler, K., Riniker, B., Rink, H., Sieber, P., and Rittel, W. (1980) The synthesis of cystine peptides by iodine oxidation of S-trityl-cysteine and S-acetamidomethyl-cysteine peptides. Helv. Chim. Acta 63, 899-915.
55. Ratner, L., Haseltine, W., Patarca, R., Livak, K J., Starcich, B., Josephs, S. F., Doran, E. R., Rafalski, J. A., Whitehorn, E. A., Baumeister, K., et al. (1985) Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature (London) 313, 277-284.
56. Braunschweiler, L., and Ernst, R. R. (1983) Coherence transfer of Isotropic mixing: application to proton correlation spectroscopy. J. Magn. Reson. 53, 521-528.
57. Shaka, A. J., Keeler, J., and Freeman, R. (1983) Evaluation of a new broadband decoupling sequence: WALTZ-16. J. Magn. Reson. 53, 313-340.
58. Rucker, S. P., and Shaka, A. J. (1989) Broadband homonuclear cross polarization in 2D NMR using DIPSI-2. Mol. Phys. 68, 509-517.
59. Piantini, U., Sorensen, O., and Ernst, R. R. (1982) J. Am. Chem. Soc. 104, 6800-6801.
60. Sklenar, V., Piotto, M., Leppik, R., and Saudek, V. (1993) Gradienttailored water suppression For H-1-N-15 Hsqc experiments optimized to retain full sensitivity. J. Magn. Reson. Series A 102, 241-245.
61. Piotto, M., Saudek, V., and Sklenar, V. (1992) Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions. J. Biomol. NMR 2, 661-665.
62. Hwang, T. L., and Shaka, A. J. (1995) Water suppression that works. Excitation sculpting using arbitrary wave-forms and pulsed-field gradients. J. Magn. Reson., Series A 112, 275-279.
63. Delaglio, F., Grzesiek, S., Vuister, G. W., Zhu, G., Pfeifer, J., and Bax, A. (1995) NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6, 277-293.
64. Johnson, B. A. (2004) Using NMRView to visualize and analyze the NMR spectra of macromolecules. Methods Mol. Biol. 278, 313-352.
65. Neidig, K. P., Geyer, M., Gorler, A., Antz, C., Saffrich, R., Beneicke, W., and Kalbitzer, H. R. (1995) Aurelia, a program for computer-aided analysis of multidimensional NMR-spectra. J. Biomol. NMR 6, 255-270.
66. Herrmann, T., Guntert, P., and Wuthrich, K. (2002) Protein NMR structure determination with automated NOE-identification in the NOESY spectra using the new software ATNOS. J. Biomol. NMR 24, 171-189.
67. Roberts, G. C. K. (1993) NMR of Macromolecules, a Parctical Approach; Oxford University Press: New York.
68. Wishart, D. S., and Sykes, B. D. (1994) Chemical shifts as a tool for structure determination. Methods Enzymol. 239, 363-392.
69. Syud, F. A., Espinosa, J. F., and Gellman, S. H. (1999) NMR-based quantification of beta-sheet populations in aqueous solution through use of reference peptides for the folded and unfolded states. J. Am. Chem. Soc. 121, 11577-11578.
70. Stanger, H. E., and Gellman, S. H. (1998) Rules for antiparallel beta-sheet design: D-Pro-Gly is superior to L-Asn-Gly for beta-hairpin nucleation. J. Am. Chem. Soc. 120, 4236-4237.
71. Espinosa, J. F., Syud, F. A., and Gellman, S. H. (2002) Analysis of the factors that stabilize a designed two-stranded antiparallel beta-sheet. Protein Sci. 11, 1492-1505.
72. Syud, F. A., Stanger, H. E., Mortell, H. S., Espinosa, J. F., Fisk, J. D., Fry, C. G., and Gellman, S. H. (2003) Influence of strand number on antiparallel beta-sheet stability in designed three- and four-stranded beta-sheets. J. Mol. Biol. 326, 553-568.
73. Wuthrich, K. (1986) NMR of Proteins and Nucleic Acids; John Wiley: New York.
74. Cierpicki, T., and Otlewski, J. (2001) Amide proton temperature coefficients as hydrogen bond indicators in proteins. J. Biomol. NMR 21, 249-261.
75. Baxter, N. J., and Williamson, M. P. (1997) Temperature dependence of 1H chemical shifts in proteins. J. Biomol. NMR 9, 359-369.
76. Vranken, W. F., Budesinsky, M., Martins, J. C., Fant, F., Boulez, K., Gras Masse, H., and Borremans, F. A. (1996) Conformational features of a synthetic cyclic peptide corresponding to the complete V3 loop of the RF HIV-1 strain in water and water/trifluoroethanol solutions. Eur. J. Biochem. 236, 100-108.